rs1871137
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_021957.4(GYS2):c.1229+11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000355 in 1,436,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000037 ( 0 hom. )
Consequence
GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.85
Publications
10 publications found
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
- glycogen storage disorder due to hepatic glycogen synthase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-21559640-C-G is Benign according to our data. Variant chr12-21559640-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 2728310.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.1229+11G>C | intron_variant | Intron 9 of 15 | ENST00000261195.3 | NP_068776.2 | ||
GYS2 | XM_024448960.2 | c.1229+11G>C | intron_variant | Intron 9 of 16 | XP_024304728.1 | |||
GYS2 | XM_006719063.4 | c.998+11G>C | intron_variant | Intron 8 of 14 | XP_006719126.1 | |||
GYS2 | XM_017019245.3 | c.*579G>C | downstream_gene_variant | XP_016874734.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.1229+11G>C | intron_variant | Intron 9 of 15 | 1 | NM_021957.4 | ENSP00000261195.2 | |||
ENSG00000285854 | ENST00000647960.1 | n.*1231+11G>C | intron_variant | Intron 16 of 22 | ENSP00000497202.1 | |||||
ENSG00000285854 | ENST00000648372.1 | n.1156+11G>C | intron_variant | Intron 9 of 10 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152082Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4
AN:
152082
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000681 AC: 17AN: 249736 AF XY: 0.000111 show subpopulations
GnomAD2 exomes
AF:
AC:
17
AN:
249736
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000366 AC: 47AN: 1284300Hom.: 0 Cov.: 20 AF XY: 0.0000509 AC XY: 33AN XY: 648526 show subpopulations
GnomAD4 exome
AF:
AC:
47
AN:
1284300
Hom.:
Cov.:
20
AF XY:
AC XY:
33
AN XY:
648526
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30372
American (AMR)
AF:
AC:
0
AN:
44450
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25080
East Asian (EAS)
AF:
AC:
0
AN:
38724
South Asian (SAS)
AF:
AC:
43
AN:
82662
European-Finnish (FIN)
AF:
AC:
0
AN:
53284
Middle Eastern (MID)
AF:
AC:
0
AN:
5446
European-Non Finnish (NFE)
AF:
AC:
0
AN:
949690
Other (OTH)
AF:
AC:
4
AN:
54592
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152082Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74276 show subpopulations
GnomAD4 genome
AF:
AC:
4
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74276
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41408
American (AMR)
AF:
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67994
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:1
Dec 16, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.